IL72589A - Immunomodulating medicaments of biological origin from klebsiella pneumoniae and escherichia coli,their preparation and pharmaceutical compositions containing them - Google Patents

Immunomodulating medicaments of biological origin from klebsiella pneumoniae and escherichia coli,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL72589A
IL72589A IL72589A IL7258984A IL72589A IL 72589 A IL72589 A IL 72589A IL 72589 A IL72589 A IL 72589A IL 7258984 A IL7258984 A IL 7258984A IL 72589 A IL72589 A IL 72589A
Authority
IL
Israel
Prior art keywords
escherichia coli
immunomodulating
klebsiella pneumoniae
medicaments
biological origin
Prior art date
Application number
IL72589A
Other versions
IL72589A0 (en
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of IL72589A0 publication Critical patent/IL72589A0/en
Publication of IL72589A publication Critical patent/IL72589A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1. Immunomodulating medicament of biological origin, of which the active principle is formed by the products of lysis or a fraction of these products of bacteria lysed by bacteriophagic route, characterised in that it contains, as active principle, the sterile lysis filtrate of at least two bacteria lysed by homologous bacteriophagic route ; the bacteria chosen being Klebsiella pneumoniae and Escherichia coli.
IL72589A 1983-08-17 1984-08-06 Immunomodulating medicaments of biological origin from klebsiella pneumoniae and escherichia coli,their preparation and pharmaceutical compositions containing them IL72589A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8313362A FR2550707B1 (en) 1983-08-17 1983-08-17 IMMUNOMODULATOR OF BIOLOGICAL MEDICINE AND PROCESS FOR PREPARING THE SAME

Publications (2)

Publication Number Publication Date
IL72589A0 IL72589A0 (en) 1984-11-30
IL72589A true IL72589A (en) 1988-01-31

Family

ID=9291646

Family Applications (1)

Application Number Title Priority Date Filing Date
IL72589A IL72589A (en) 1983-08-17 1984-08-06 Immunomodulating medicaments of biological origin from klebsiella pneumoniae and escherichia coli,their preparation and pharmaceutical compositions containing them

Country Status (22)

Country Link
EP (1) EP0139551B1 (en)
JP (1) JPS6069022A (en)
AT (1) ATE36240T1 (en)
AU (1) AU564652B2 (en)
CA (1) CA1229566A (en)
CS (1) CS270410B2 (en)
DD (1) DD232432A5 (en)
DE (1) DE3473228D1 (en)
DK (1) DK160807C (en)
ES (1) ES535213A0 (en)
FR (1) FR2550707B1 (en)
HU (1) HU193217B (en)
IL (1) IL72589A (en)
IN (1) IN161616B (en)
MA (1) MA20203A1 (en)
NO (1) NO843274L (en)
NZ (1) NZ209171A (en)
OA (1) OA07794A (en)
PT (1) PT79090B (en)
SU (1) SU1487815A3 (en)
YU (1) YU143284A (en)
ZA (1) ZA846151B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876194A (en) * 1986-07-22 1989-10-24 Hightech Receptor Ab Protein L and subfragments thereof, with immunoglobulin binding activity, a process for preparing thereof, reagent kit, pharmaceutical composition and a peptococcus magnus strain
FR2620130B1 (en) * 1987-09-08 1990-01-12 Lipha NOVEL WATER-SOLUBLE POLYSACCHARIDES, PROCESS FOR OBTAINING THEM, USE THEREOF AS MEDICAMENTS AND PREPARATION CONTAINING THEM
IL88480A0 (en) * 1987-11-27 1989-06-30 Univ Toronto Proteinaceous compositions
WO1997045530A1 (en) * 1996-05-27 1997-12-04 UZILOVA, Irina Semenovna, Heiress of UZILOV Use of streptococcus faecium strains and composition containing the same
CA2476405C (en) 2002-02-13 2011-10-11 Immunology Laboratories, Inc. Compositions and methods for treatment of microbial infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758977A (en) * 1969-11-17 1971-05-17 Glaxo Lab Ltd BIOCHEMICAL PROCESS
CH633188A5 (en) * 1978-05-26 1982-11-30 Om Laboratoires Sa MEDICINE FOR INFECTIOUS DISEASES OF THE RESPIRATORY TRACT.
CH639852A5 (en) * 1979-07-26 1983-12-15 Om Laboratoires Sa MEDICINE AGAINST INFECTIOUS DISEASES OF THE URINARY AND DIGESTIVE PATHWAYS.
US4322405A (en) * 1981-04-06 1982-03-30 Laboratoires Om Societe Anonyme Method for treating rheumatoid arthritis

Also Published As

Publication number Publication date
DK160807C (en) 1991-10-07
ES8602415A1 (en) 1985-12-01
ES535213A0 (en) 1985-12-01
DE3473228D1 (en) 1988-09-15
EP0139551A3 (en) 1985-07-10
ATE36240T1 (en) 1988-08-15
YU143284A (en) 1991-02-28
ZA846151B (en) 1985-03-27
FR2550707A1 (en) 1985-02-22
FR2550707B1 (en) 1986-02-28
SU1487815A3 (en) 1989-06-15
NZ209171A (en) 1988-10-28
AU564652B2 (en) 1987-08-20
MA20203A1 (en) 1985-04-01
AU3193884A (en) 1985-02-21
DD232432A5 (en) 1986-01-29
IL72589A0 (en) 1984-11-30
OA07794A (en) 1986-11-20
CS270410B2 (en) 1990-06-13
PT79090B (en) 1986-08-14
IN161616B (en) 1988-01-02
EP0139551A2 (en) 1985-05-02
DK393884A (en) 1985-02-18
HU193217B (en) 1987-08-28
DK160807B (en) 1991-04-22
JPS6069022A (en) 1985-04-19
CS592184A2 (en) 1989-11-14
EP0139551B1 (en) 1988-08-10
CA1229566A (en) 1987-11-24
PT79090A (en) 1984-09-01
DK393884D0 (en) 1984-08-16
HUT35013A (en) 1985-05-28
NO843274L (en) 1985-02-18

Similar Documents

Publication Publication Date Title
GR3006177T3 (en)
IT8520672A0 (en) COMPOSITE CONTAINER FOR STERILE SOLID PRODUCTS.
SE8404065D0 (en) NOVEL BIOLOGICALLY ACTIVE COMPOUNDS
IL72589A (en) Immunomodulating medicaments of biological origin from klebsiella pneumoniae and escherichia coli,their preparation and pharmaceutical compositions containing them
IL85992A0 (en) Dihydropyridinamides,their preparation and pharmaceutical compositions containing them
AU573899B2 (en) Pyrazolo(3,4-b)-pyridine amided
IL108997A0 (en) Heterotricyclically substituted phenyl-cyclohexane-carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
MC1977A1 (en) PROCESS FOR THE PREPARATION OF AN INHIBITOR OR DESTRUCTIVE COMPOSITION OF AT LEAST ONE SINGLE-CELL LIVING BEING CONTAINING FLUOR F AND LITHIUM LI +
EP0226842A3 (en) Substituted 1,4-naphthalenediones, processes for their preparation and pharmaceutical compositions containing them
IL106289A (en) Phospholipid derivatives their preparation and pharmaceutical compositions containing them
ZA873970B (en) Pharmaceutical formulation for the treatment of bacterial infections
IL107141A0 (en) Phospholipid derivatives containing higher elements of the vth main group,their preparation and pharmaceutical compositions containing them
HUT42492A (en) Process for producing cepheme-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents